| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 249992 | M-AMSA | 0.0108954273764103 | 0.13644139 |
| NSC 604586 | 2-Butenamide, N-(4-chlorophenyl)-4,4,4-trichloro- | 0.0108954273764103 | 0.29099037 |
| NSC 622075 | Null | 0.0108954273764103 | 0.52565353 |
| NSC 622124 | Molybdate(6-), hexatriaconta-.mu.-oxooctadecaoxobis[.mu.9-[phosphato(3-)-.kappa.O:.kappa.O:.kappa.O:.kappa.O':.kappa.O':.kappa.O'':.kappa.O'':.kappa.O''':.kappa.O''']]octadeca-, hexapotassium (9CI) | 0.0108954273764103 | 0.18160931 |
| NSC 645210 | 1,4-Naphthalenedione, 2-chloro-3-[[2-(2-fluorophenyl)- 1-oxoethyl]amino]- | 0.0108954273764103 | 0.29733645 |
| NSC 647328 | Null | 0.0108954273764103 | 0.42441421 |
| NSC 654509 | Pirarubicin HCl | 0.0108954273764103 | 0.19017676 |
| NSC 658088 | Null | 0.0108954273764103 | 0.2477181 |
| NSC 674915 | Null | 0.0108954273764103 | 0.1453268 |
| NSC 677696 | Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]- tert-butyl ester | 0.0108954273764103 | 0.22765217 |